GlobeNewswire (press release) ... Dr. Schaible's group designed and conducted the SONIC trial in Crohn's disease, a major clinical trial published in the New England Journal of Medicine, demonstrating the superiority of REMICADE® versus a conventional immunomodulator (azathioprine) ...
Vancouver Sun The same vaccine has also been used as a treatment in some forms of bladder cancer. The immune-stimulating therapy which Qu has patented is referred to as a Site Specific Immunomodulator (SSI). It is considered novel because of the way the bacterial ... and more »
